Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.

L Wilkoff, Bruce; Boriani, Giuseppe; Mittal, Suneet; E Poole, Jeanne; Kennergren, Charles; Ralph Corey, G; D Krahn, Andrew; J Schloss, Edward; L Gallastegui, Jose; A Pickett, Robert; F Evonich, Rudolph; F Roark, Steven; M Sorrentino, Denise; P Sholevar, Darius; M Cronin, Edmond; J Berman, Brett; W Riggio, David; H Khan, Hafiza; T Silver, Marc; Collier, Jack; Eldadah, Zayd; Holbrook, Reece; D Lande, Jeff; R Lexcen, Daniel; Seshadri, Swathi; G Tarakji, Khaldoun

doi:10.1161/circep.120.008503

Public

Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.

Published in Circulation. Arrhythmia and electrophysiology • Oct 1, 2020

NobleIDark:/48914/w1/20260526/C0FF02F8Record on NobleID

Authors:

Bruce L Wilkoff

,

Giuseppe Boriani

,

Suneet Mittal

Abstract

BACKGROUND: In the WRAP-IT trial (Worldwide Randomized Antibiotic Envelope Infection Prevention), adjunctive use of an absorbable antibacterial envelope resulted in a 40% reduction of major cardiac implantable electronic device infection without increased risk of complication in 6983 patients underg...

Subject

defibrillators

incidence

infections

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!